Related Experiment Video
Updated: Jun 7, 2026
08:40
Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
Mitochondrial uncoupling protein 2 in pancreatic β-cells
M D Brand1, N Parker, C Affourtit
1Buck Institute for Age Research, Novato, CA 94945, USA. mbrand@buckinstitute.org
Diabetes, Obesity & Metabolism
|October 30, 2010
Summary
Uncoupling protein 2 (UCP2) dynamically regulates insulin secretion in pancreatic beta cells. Rapid proteasomal degradation of UCP2 fine-tunes glucose-stimulated insulin secretion (GSIS), offering a novel regulatory mechanism.
Area of Science:
- Cellular bioenergetics
- Metabolic regulation
- Endocrinology
Background:
- Pancreatic beta cells utilize glucose to regulate insulin secretion via ATP/ADP ratio.
- Uncoupling protein 2 (UCP2) influences oxidative phosphorylation efficiency and potentially glucose-stimulated insulin secretion (GSIS).
- Previous studies on UCP2 knockout mice yielded conflicting results regarding GSIS and glucose tolerance.
Purpose of the Study:
- To investigate the role of Uncoupling protein 2 (UCP2) in regulating glucose-stimulated insulin secretion (GSIS).
- To elucidate the regulatory mechanisms controlling UCP2 protein levels in pancreatic beta cells.
Main Methods:
- Acute UCP2 knockdown in INS-1E insulinoma cells to assess GSIS.
- Analysis of UCP2 protein dynamics, including proteolysis and synthesis.
- Investigation of proteasomal degradation pathway for UCP2 using inhibitors and in vitro reconstitution.
Main Results:
- Acute UCP2 knockdown robustly enhanced GSIS in INS-1E cells, confirming UCP2's inhibitory role.
- UCP2 protein levels are dynamically regulated by rapid proteolysis (half-life < 1 hour) and synthesis.
- UCP2 degradation is proteasome-dependent, a pathway previously uncharacterized for UCP2 and UCP3.
Conclusions:
- UCP2 acts as a negative regulator of glucose-stimulated insulin secretion (GSIS).
- Rapid, proteasome-mediated degradation of UCP2 provides a fine-tuning mechanism for GSIS.
- This dynamic regulation of UCP2 offers a novel insight into beta-cell bioenergetics and insulin secretion control.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...